Schering-Plough
SGP
#545
Rank
ยฃ34.22 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Schering-Plough (SGP) - Total debt

Total debt on the balance sheet as of December 2008 : ยฃ6.05 Billion

According to Schering-Plough's latest financial reports the company's total debt is ยฃ6.05 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Schering-Plough - Total debt on balance sheet (from 1996 to 2008)

Total debt by year

Year Total debt Change
2008-12-31ยฃ5.57 B
2006-12-31ยฃ1.35 B-36.41%
2005-12-31ยฃ2.13 B3.35%
2004-12-31ยฃ2.06 B7.51%
2003-12-31ยฃ1.91 B-28.65%
2002-12-31ยฃ2.68 B105.27%
2001-12-31ยฃ1.31 B-25.63%
2000-12-31ยฃ1.76 B
1998-12-31ยฃ1.23 B-17.43%
1997-12-31ยฃ1.49 B130.31%
1996-12-31ยฃ0.64 B